Try a new search

Format these results:

Searched for:

in-biosketch:true

person:segevd01

Total Results:

1158


Clinical Protection During the First Omicron Wave in Unvaccinated, Convalescent US Adults-Reply [Comment]

Alejo, Jennifer L; Makary, Martin A; Segev, Dorry L
PMID: 35819425
ISSN: 1538-3598
CID: 5279852

Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case series [Letter]

Chang, Amy; Mitchell, Jonathan; Alejo, Jennifer L; Chiang, Teresa P Y; Abedon, Aura T; Kim, Jake D; Avery, Robin K; Tobian, Aaron A R; Levan, Macey L; Warren, Daniel S; Garonzik-Wang, Jacqueline M; Massie, Allan B; Segev, Dorry L; Werbel, William A
PMID: 35822545
ISSN: 1399-0012
CID: 5279872

Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave

Alejo, Jennifer L; Chiang, Teresa P Y; Bowles Zeiser, Laura; Kim, Jake D; Mitchell, Jonathan; Avery, Robin K; Tobian, Aaron A R; Abedon, Rivka R; Levan, Macey L; Warren, Daniel S; Garonzik-Wang, Jacqueline M; Massie, Allan B; Segev, Dorry L; Werbel, William A
PMID: 35655363
ISSN: 1534-6080
CID: 5283552

Letter to the editor: Six-month antibody kinetics and durability in liver transplant recipients after two doses of SARS-CoV-2 mRNA vaccination [Letter]

Chang, Amy; Strauss, Alexandra T; Alejo, Jennifer L; Chiang, Teresa P-Y; Hernandez, Nicole F; Zeiser, Laura B; Boyarsky, Brian J; Avery, Robin K; Tobian, Aaron A R; Levan, Macey L; Warren, Daniel S; Garonzik-Wang, Jacqueline M; Massie, Allan B; Werbel, William A; Segev, Dorry L
PMID: 35791054
ISSN: 2471-254x
CID: 5280322

Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

Teles, Mayan S; Connolly, Caoilfhionn M; Wallwork, Rachel; Frey, Sarah; Chiang, Teresa Po-Yu; Alejo, Jennifer L; Albayda, Jemima; Christopher-Stine, Lisa; Segev, Dorry L; Werbel, William A; Paik, Julie J
PMID: 35758603
ISSN: 1462-0332
CID: 5281052

Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist

Chen, Xiaomeng; Chu, Nadia M; Basyal, Pragyashree Sharma; Vihokrut, Wasurut; Crews, Deidra; Brennan, Daniel C; Andrews, Sarah R; Vannorsdall, Tracy D; Segev, Dorry L; McAdams-DeMarco, Mara A
Introduction/UNASSIGNED:Depressive symptoms, even without a clinical diagnosis of depression, are common in kidney failure patients and may be a barrier to completing the complex process of kidney transplant (KT) evaluation. We assessed depressive symptom burden and association between depressive symptoms and access to KT waitlist by age. Methods/UNASSIGNED:In a prospective cohort of 3728 KT patients (aged 18-88 years), the Center for Epidemiologic Studies-Depression (CES-D) scale was used to measure depressive symptoms at evaluation. Depressive symptom severity was defined as follows: none: 0; minimal: 1 to 15; mild: 16 to 20; moderate: 21 to 25; severe: 26 to 60. Hazard ratios (HRs) of active listing within 1 year after evaluation were estimated using Cox proportional hazards models, adjusted for clinical and social factors. Results/UNASSIGNED: < 0.001). After adjustment, every 5-point higher CES-D score (more depressive symptoms) was associated with a 13% lower chance of listing (HR = 0.87, 95% CI: 0.85-0.90); the strongest association was found among patients aged ≥70 years (adjusted HR [aHR] = 0.73, 95% CI: 0.62-0.86). Furthermore, minimal (HR = 0.69, 95% CI: 0.60-0.79), mild (HR = 0.57, 95% CI: 0.44-0.72), moderate (HR = 0.53, 95% CI: 0.39-0.71), and severe (HR = 0.44, 95% CI: 0.34-0.57) depressive symptoms were all associated with a lower chance of listing. Conclusion/UNASSIGNED:Older candidates were less likely to report depressive symptoms at KT evaluation. Regardless of age, candidates who did report depressive symptoms, and even minimal symptoms, had a lower chance of listing. Transplant centers should routinely screen patients for depressive symptoms and refer the affected patients to mental health services to improve access to KT.
PMCID:9174041
PMID: 35694557
ISSN: 2468-0249
CID: 5282482

Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses [Letter]

Chang, Amy; Chiang, Teresa Py; Kim, Jake D; Mitchell, Jonathan; Alejo, Jennifer L; Jefferis, Alexa A; Avery, Robin K; Tobian, Aaron A R; Levan, Macey L; Warren, Daniel S; Garonzik-Wang, Jacqueline M; Massie, Allan B; Segev, Dorry L; Werbel, William A
PMID: 35670813
ISSN: 1399-0012
CID: 5283132

Questions of accountability and transparency in the US organ donation and transplantation system [Letter]

Levan, Macey L; Klitenic, Samantha; Massie, Allan; Parent, Brendan; Caplan, Arthur; Gentry, Sommer; Segev, Dorry
PMID: 35710989
ISSN: 1546-170x
CID: 5282752

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease

Connolly, Caoilfhionn M; Frey, Sarah; Chiang, Teresa Po-Yu; Teles, Mayan; Alejo, Jennifer L; Albayda, Jemima; Shah, Ami A; Werbel, William A; Segev, Dorry L; Christopher-Stine, Lisa; Paik, Julie J
PMCID:9129174
PMID: 35583259
ISSN: 1462-0332
CID: 5284282

Reply: How liver allocation should weigh Model for End-Stage Liver Disease, posttransplant survival, distance, and access [Letter]

VanDerwerken, Douglas N; Wood, Nick L; Segev, Dorry L; Gentry, Sommer E
PMID: 35689612
ISSN: 1527-3350
CID: 5283312